Creative Financial Designs’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.3M | Sell |
15,013
-3,111
| -17% | -$298K | 0.08% | 201 |
|
|
2025
Q4 | $1.74M | Sell |
18,124
-9,265
| -34% | -$900K | 0.11% | 164 |
|
|
2025
Q3 | $2.61M | Buy |
27,389
+486
| +2% | +$44.7K | 0.18% | 119 |
|
|
2025
Q2 | $2.35M | Buy |
26,903
+997
| +4% | +$84.6K | 0.17% | 128 |
|
|
2025
Q1 | $2.33M | Buy |
25,906
+1,347
| +5% | +$121K | 0.19% | 108 |
|
|
2024
Q4 | $1.96M | Sell |
24,559
-225
| -0.9% | -$19.5K | 0.16% | 123 |
|
|
2024
Q3 | $2.23M | Buy |
24,784
+857
| +4% | +$72.1K | 0.19% | 108 |
|
|
2024
Q2 | $1.88M | Buy |
23,927
+1,145
| +5% | +$93.9K | 0.17% | 116 |
|
|
2024
Q1 | $1.99M | Buy |
22,782
+3,001
| +15% | +$256K | 0.19% | 107 |
|
|
2023
Q4 | $1.63M | Buy |
19,781
+1,708
| +9% | +$130K | 0.17% | 118 |
|
|
2023
Q3 | $1.42M | Buy |
18,073
+144
| +0.8% | +$12.1K | 0.17% | 114 |
|
|
2023
Q2 | $1.58M | Sell |
17,929
-118
| -0.7% | -$10.2K | 0.19% | 104 |
|
|
2023
Q1 | $1.45M | Buy |
18,047
+894
| +5% | +$72.9K | 0.19% | 109 |
|
|
2022
Q4 | $1.33M | Buy |
17,153
+2,068
| +14% | +$168K | 0.2% | 102 |
|
|
2022
Q3 | $1.22M | Buy |
15,085
+2,051
| +16% | +$184K | 0.2% | 100 |
|
|
2022
Q2 | $1.17M | Buy |
13,034
+1,205
| +10% | +$122K | 0.19% | 110 |
|
|
2022
Q1 | $1.31M | Buy |
11,829
+3,304
| +39% | +$349K | 0.2% | 109 |
|
|
2021
Q4 | $882K | Buy |
8,525
+512
| +6% | +$59.3K | 0.13% | 138 |
|
|
2021
Q3 | $1M | Buy |
8,013
+520
| +7% | +$67.3K | 0.17% | 116 |
|
|
2021
Q2 | $930K | Buy |
7,493
+784
| +12% | +$98.4K | 0.16% | 118 |
|
|
2021
Q1 | $793K | Buy |
6,709
+2,892
| +76% | +$339K | 0.16% | 121 |
|
|
2020
Q4 | $447K | Sell |
3,817
-3,443
| -47% | -$379K | 0.1% | 159 |
|
|
2020
Q3 | $754K | Buy |
7,260
+271
| +4% | +$27.2K | 0.19% | 100 |
|
|
2020
Q2 | $641K | Buy |
6,989
+3,538
| +103% | +$339K | 0.19% | 94 |
|
|
2020
Q1 | $311K | Sell |
3,451
-1
| -0% | -$106 | 0.16% | 87 |
|
|
2019
Q4 | $395K | Sell |
3,452
-26
| -0.7% | -$2.85K | 0.18% | 107 |
|
|
2019
Q3 | $368K | Sell |
3,478
-70
| -2% | -$7.3K | 0.2% | 92 |
|
|
2019
Q2 | $348K | Buy |
3,548
+2,342
| +194% | +$214K | 0.19% | 93 |
|
|
2019
Q1 | $110K | Buy |
1,206
+58
| +5% | +$5.19K | 0.07% | 156 |
|
|
2018
Q4 | $104K | Sell |
1,148
-91
| -7% | -$8.5K | 0.08% | 143 |
|
|
2018
Q3 | $122K | Sell |
1,239
-3,090
| -71% | -$286K | 0.07% | 147 |
|
|
2018
Q2 | $371K | Sell |
4,329
-29
| -0.7% | -$2.42K | 0.22% | 90 |
|
|
2018
Q1 | $350K | Buy |
4,358
+136
| +3% | +$11.2K | 0.22% | 91 |
|
|
2017
Q4 | $341K | Buy |
4,222
+1,078
| +34% | +$86.3K | 0.23% | 87 |
|
|
2017
Q3 | $244K | Sell |
3,144
-300
| -9% | -$24.9K | 0.14% | 122 |
|
|
2017
Q2 | $306K | Sell |
3,444
-40
| -1% | -$3.37K | 0.2% | 104 |
|
|
2017
Q1 | $281K | Sell |
3,484
-60
| -2% | -$4.69K | 0.2% | 110 |
|
|
2016
Q4 | $252K | Buy |
+3,544
| New | +$278K | 0.21% | 99 |
|
Other funds holding MDT
VCM
VPM
Creative Financial Designs's MDT Position: Q1 2026 in Review
Creative Financial Designs reduced its Medtronic (MDT) stake by 17% in Q1 2026, selling an estimated $298K and leaving 15,013 shares worth $1.3M. The position accounts for 0.08% of the portfolio, ranked #201.
Creative Financial Designs first reported a position in MDT in Q4 2016 and has held it in 38 quarters since. The position peaked at $2.61M in Q3 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Creative Financial Designs held 15,013 shares of Medtronic worth $1.3M as of Q1 2026.
- Creative Financial Designs sold 3,111 Medtronic shares in Q1 2026, an estimated $298K.
- Medtronic made up 0.08% of Creative Financial Designs's portfolio in Q1 2026, its #201 holding.
- Creative Financial Designs first reported a position in Medtronic in Q4 2016 and has held it in 38 quarters since.
- Creative Financial Designs's Medtronic position peaked at $2.61M in Q3 2025.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Creative Financial Designs's 13F filing for Q1 2026, filed 13 Apr 2026.